Spotlights

Home/Spotlights

California Life Sciences Industry Report Highlights Continued Strong Growth

BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports, special features and more. Today's feature is a Q&A with Sara Radcliffe, President & CEO, California Life Sciences [...]

November 14th, 2018|

Spotlight: Biotech Companies in the “Big 3” Regions Rake in the Cash

  BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports and other resources focusing on financing and dealmaking. This feature is from DealForma, the biopharma database providing you [...]

November 13th, 2018|

Spotlight: What Small and Emerging Companies Need When Entering Into Dealmaking Discussions

BioWeekSF will soon be here again -- January 6-11, 2019 -- the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation,  the week's premium online guide, BioWeekSF.com, is sponsoring a series of viewpoints and more from leaders and professionals involved in life sciences/healthcare dealmaking. As Chair of Foley Hoag's Licensing & [...]

October 14th, 2018|

Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development Symposium

The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on [...]

July 7th, 2017|

Spotlight: Every Challenge. Every Day. Every Voice.

Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. So what happens when a patient meets the people that helped save her life? Watch this 8-minute documentary as Ginger Tam, a lung-cancer patient, meets the researchers who worked on her cancer treatment.  

March 1st, 2017|

Biocept Demonstrates the Solid Future of Liquid Biopsies

A recent mendelspod podcast profiles Biocept, its CEO and future of liquid biopsies - an overview and an excerpt: Michael Nall, CEO of Biocept Chapters: 0:00 A $20 billion market 4:09 How many tests have you sold to date? 6:36 At what point will the liquid biopsy be preferred to solid tumor biopsy? 11:07 [...]

May 21st, 2016|

Upcoming Event Spotlight: World Biosimilar Congress, May 19-20

Following the release of the FDA’s purple book, the World Biosimilar Congress (WBC) USA launched in 2015 to bring focus to the important and distinct issues facing the biopharmaceutical industry. When it comes to developing and commercializing biosimilars in the United States from the payer or biosimilar manufacturing perspective, WBC is the largest event in [...]

May 9th, 2016|

Event Recap: BIO 2015 in Philadelphia

By Dr Kristophe Diaz, Big3Bio East Coast Consultant This year’s BIO Convention was held in Philadelphia at the Pennsylvania Convention Center, and the 150,000 square feet of convention space gave 1,800 exhibitors a chance to showcase their technologies, capabilities, and, for many countries and 47 states and regions, an opportunity to share a snapshot of [...]

June 30th, 2015|

Innovation@ Biomedical Sciences (BMS) Ph.D. Program at UCSD Health Sciences

Mission The Biomedical Sciences (BMS) Ph.D. program is sponsored by UCSD Health Sciences. Its mission is to offer advanced and multidisciplinary training in basic and disease-oriented research. The program's goal is to develop future generations of innovative biomedical scientists who will create new knowledge, solve problems and contribute to the health and well being of [...]

April 14th, 2014|
X